Search

Your search keyword '"Pontiggia S"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Pontiggia S" Remove constraint Author: "Pontiggia S"
40 results on '"Pontiggia S"'

Search Results

2. Altro che terza missione! Periferie e cambiamento

3. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

4. Altro che terza missione! Periferie e cambiamento

7. The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age

8. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

15. Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patient

17. Il ricordo è del passato?

19. Il ricordo è del passato?

20. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians

21. Il Morandi di Guttuso

23. Non-O1/non-O139 Vibrio cholerae bacteraemia and cholangitis: an unusual case in an oncological patient in Lecco Hospital, Italy.

24. Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy).

26. Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients.

27. Early psychological intervention in adult patients after hospitalization during COVID-19 pandemia. A single center observational study.

28. IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.

29. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians.

30. Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura.

31. The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age.

32. Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry.

33. Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series.

34. ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura.

35. Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis.

36. Congenital and acquired ADAMTS13 deficiency: Two mechanisms, one patient.

37. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.

38. Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.

39. FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.

40. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.

Catalog

Books, media, physical & digital resources